![Bill Colone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Bill Colone is currently the Chief Executive Officer at Singlepass, Inc. He was previously the Chief Executive Officer at UroDev Medical.
Actieve functies van Bill Colone
Bedrijven | Functie | Begin |
---|---|---|
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Algemeen Directeur | - |
Eerdere bekende functies van Bill Colone
Bedrijven | Functie | Einde |
---|---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Health Technology |
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |